LOGIN
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
August 2013
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin
J Bone Joint Surg Am. 2010 Mar;92(3):527-35Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
OE EXCLUSIVE
Dr. Colwell discusses his study assessing the safety of a mobile compression device for thrombo-prophylaxis.
Synopsis
386 patients (>18 yr) who had been scheduled for 389 total hip arthroplasties were randomized to receive thromboprophylaxis by either a mobile compression device (CECT SFT) or standardly accepted low-molecular-weight heparin (LMWH).The CECT SFT demonstrated effective thromboprophylaxis with a better safety profile (fewer major bleeding events) compared to LMWH.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.